As the G2019S mutation in LRRK2 is the most common cause of late onset PD, it serves as good platform to investigate the effects of PD-associated genetic defects on the microglial fitness and behavior, especially because of its association with immunity and microglia. This evidence concerns the gene LRRK2 and Parkinson disease.